Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Antonio, TX
NPI
1114934403
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
701 S Zarzamora St
San Antonio, TX, 78207
Phone (210) 358-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
304 services
Medicare patients, 2024
60
Average age 68
Drug cost, 2024
$2.5M
3,545 prescriptions
Company payments, 2025
$873
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aruna Venkatesh was code 99214 (office e&m - established), 165 times for 58 patients. In total Aruna Venkatesh billed 304 services in 9 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 165 | 58 | $64.35 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 81 | 41 | $12.42 | $1,006 |
| 95251 Test - Miscellaneous | Office | 41 | 18 | $25.11 | $1,030 |
By year: 2022 $15K for 271 services; 2023 $13K for 213 services; 2024 $14K for 304 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aruna Venkatesh prescribed most often to Medicare patients was Ozempic (Semaglutide), with 337 prescriptions and refills. In total Aruna Venkatesh wrote 3,545 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 337 | 640 | 76 | $590K |
| Levothyroxine Sodium Generic | 264 | 724 | 76 | $2,760 |
| Farxiga Dapagliflozin Propanediol | 264 | 553 | 72 | $295K |
| Trulicity Dulaglutide | 237 | 420 | 52 | $393K |
| Tresiba Flextouch U-200 Insulin Degludec | 208 | 543 | 56 | $272K |
| Metformin Hcl Generic | 206 | 578 | 64 | $2,065 |
| Jardiance Empagliflozin | 162 | 336 | 46 | $190K |
| Mounjaro Tirzepatide | 150 | 208 | 24 | $210K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 128 | 372 | 44 | $19K |
| Humalog Kwikpen U-100 Insulin Lispro | 118 | 336 | 46 | $42K |
| Novolog Flexpen Insulin Aspart | 107 | 260 | 41 | $41K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 100 | 263 | 43 | $15K |
| Metformin Hcl Er Metformin Hcl | 91 | 254 | 34 | $1,134 |
| Tradjenta Linagliptin | 65 | 167 | 23 | $82K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 63 | 152 | 27 | $22K |
Brand drugs: 2,408 claims; generic drugs: 701 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aruna Venkatesh $873 ($873 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $701.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.